Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants

NCT06830954 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Group A
DRUG: Reference Group

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.